Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness


Conjugate Vaccine
Streptococcus pneumoniae


Globally, lower respiratory tract infections (LRTIs), including community-acquired pneumonia (CAP), cause considerable of morbidity and mortality in adults, especially in the elderly. In addition to age, underlying medical conditions are associated with an increased risk of CAP. From an aetiological point of view, Streptococcus pneumoniae is the leading cause of adult CAP throughout the world. Two types of vaccine are available for the prevention of pneumococcal diseases: the pneumococcal polysaccharide vaccine (PPV23) and the pneumococcal conjugate vaccine (PCV7, PCV10 and PCV13). An accurate understanding of the LRTIs burden and the types of subjects at risk of CAP, allow to find an appropriately targeted immunization strategy and provide baseline data to evaluate pneumococcal vaccine effectiveness. Given the high variability in available estimates of LRTIs burden and associated risk factors, the objective of the study was to discuss the methodological criticism in its evaluation, in the light of the gradual introduction of PCV13 immunization strategy targeted to elderly and risk groups in middle-high income countries.


Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44. [Google Scholar]

Lim WS, Baudouin SV, George RC, et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009;64. Available from: PubMed PMID: 19783532. doi: 10.1136/thx.2009.121434. [Google Scholar]

Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2010 Aug;67(1):71-79. Available from: PubMed PMID: 20729232. doi: 10.1136/thx.2009.129502. [Google Scholar]

Blasi F, Mantero M, Santus P, Tarsia P. Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect 2012;18:7-14. Available from: PubMed PMID: 22882668. doi: 10.1111/j.1469-0691.2012.03937.x. [Google Scholar]

Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128

European Commission , author . Atlas on mortality in the European Union. Luxembourg: Office for Official Publications of the European Communities; 2008. [Google Scholar]

book, l.w. (European) . 2nd edn. Sheffield, UK: European Respiratory Society/European Lung-foundation; 2003. [Google Scholar]

Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, et al. Aging population and future burden of pneumococcal pneumonia in the United States.. J Infect Dis 2012 Mar;205(10):1589-1592. Available from: PubMed PMID: 22448012. doi: 10.1093/infdis/jis240. [Google Scholar]

Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J 2000;15(4):757-763. Available from: doi: 10.1034/j.1399-3003.2000.15d21.x. [Google Scholar]

Simmerman JM, Chittaganpitch M, Levy J, Chantra S, Maloney S, Uyeki T, et al. Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.. PLoS One 2009 Nov;4(11). Available from: PubMed PMID: 19936224. doi: 10.1371/journal.pone.0007776. [Google Scholar]

Gutiérrez F, Masiá M, Mirete C, Soldán B, Carlos Rodríguez, J,, , Padilla S, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. Journal of Infection 2006;53(3):166-174. Available from: doi: 10.1016/j.jinf.2005.11.006. [Google Scholar]

Millett ERC, Quint JK, Smeeth L, Daniel RM, Thomas SL. Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study. . Available from: PubMed PMID: 3770598. doi: [Google Scholar]

Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, et al. Pneumonia: still the old man's friend?. Arch Intern Med 2003 Feb;163(3):317-323. Available from: PubMed PMID: 12578512. doi: 10.1001/archinte.163.3.317. [Google Scholar]

Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review.. Thorax 2013;68(11):1057-1065. Available from: PubMed PMID: 24130229. doi: 10.1136/thoraxjnl-2013-204282. [Google Scholar]

Ansaldi F, Orsi A, Trucchi C, De Florentiis D, Ceravolo A, Coppelli M, et al. Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults. Hum Vaccin Immunother 2014 Nov;11(1):166-171. Available from: PubMed PMID: 25483530. doi: 10.4161/hv.34419. [Google Scholar]

Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL , AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratalà J, Chang FY, Charles PG, Diaz AA, Domínguez J, Ehara N, Endeman H, Falcó V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Mareković I, Masiá M, Matta MA, Miró Ò, Murdoch DR, Nuermberger E, Paolini R, Perelló R, Snijders D, Plečko V, Sordé R, Strålin K, van der Eerden MM, Vila-Corcoles A, Watt JP. . Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.. . PubMed PMID: 23565216. [Google Scholar]

Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.. Antimicrob Agents Chemother 2014 Jun;58(9):5262-5268. Available from: PubMed PMID: 24957843. doi: 10.1128/AAC.02582-14. [Google Scholar]

World Health Organization , author . Pneumococcal vaccines. WHO position paper 2012. Wkly Epidemiol Rec 2012;87:129. [Google Scholar]

Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia.. Clin Infect Dis 2011;52 Suppl 4. Available from: PubMed PMID: 21460288. doi: 10.1093/cid/cir045. [Google Scholar]

Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, Abe M, Aoshima M, Ariyoshi K , Adult Pneumonia Study Group-Japan (APSG-J). . The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study.. . PubMed PMID: 25822890. doi: 10.1371/journal.pone.0122247. [Google Scholar]

Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.. Thorax 2009 May;64(12):1062-1069. Available from: PubMed PMID: 19454409. doi: 10.1136/thx.2008.109785. [Google Scholar]

Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 2012 Feb;67(6):540-545. Available from: PubMed PMID: 22374921. doi: 10.1136/thoraxjnl-2011-201092. [Google Scholar]

Marston BJ, Plouffe JF, File Jr, T.M. , Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.. Arch Intern Med 1997;157(15):1709-1718. Available from: PubMed PMID: 9250232. [Google Scholar]

Kornum JB, Due KM, Nørgaard M, Tjønneland A, Overvad K, Sørensen HT, et al. Alcohol drinking and risk of subsequent hospitalisation with pneumonia. Eur Respir J 2011 Jun;39(1):149-155. Available from: PubMed PMID: 21659417. doi: 10.1183/09031936.00000611. [Google Scholar]

Schnoor M, Hedicke J, Dalhoff K, et al. CAPNETZ study group. Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 2007;55(3):233-239. Available from: doi: 10.1016/j.jinf.2007.04.355. [Google Scholar]

Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.. Am J Epidemiol 1993 May;137(9):977-988. Available from: PubMed PMID: 8317455. [Google Scholar]

Watt JP, Moïsi JC, Donaldson RL, et al. Measuring the incidence of adult community-acquired pneumonia in a Native American community. Epidemiol Infect 2010;138(08):1146-1154. Available from: doi: 10.1017/S0950268809991464. [Google Scholar]

Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study.. Clin Infect Dis 2004;39(11):1642-1650. Available from: PubMed PMID: 15578365. doi: 10.1086/425615. [Google Scholar]

Capelastegui A, España PP, Bilbao A, et al. Poblational Study of Pneumonia (PSoP) Group. Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care. J Infect 2010;61(5):364-371. Available from: PubMed PMID: 20692290. doi: 10.1016/j.jinf.2010.07.015. [Google Scholar]

Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England.. Emerg Infect Dis 2008;14(5):727-733. Available from: PubMed PMID: 18439353. doi: 10.3201/eid1405.071011. [Google Scholar]

Davies SC. Annual Report of the Chief Medical Officer. London: Department of Health; 2012. [Google Scholar]

Myles PR, McKeever TM, Pogson Z, Smith CJP, Hubbard RB. The incidence of pneumonia using data from a computerized general practice database. Epidemiol Infect 2008 Oct;137(5):709-716. Available from: PubMed PMID: 18840320. doi: 10.1017/S0950268808001428. [Google Scholar]

Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56(2):109-114. Available from: PubMed PMID: 11209098. doi: 10.1136/thorax.56.2.109. [Google Scholar]

Takaki M, Nakama T, Ishida M, Morimoto H, Nagasaki Y, Shiramizu R, et al. High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance.. Jpn J Infect Dis 2014;67(4):269-275. Available from: PubMed PMID: 25056072. doi: 10.7883/yoken.67.269. [Google Scholar]

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, et al. EPIVAC Study Group, author. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009;103(2):309-316. Available from: doi: 10.1016/j.rmed.2008.08.006. [Google Scholar]

Ludwig E, Bonanni P, Rohde G, Sayiner A, Torres A. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev 2012 Mar;21(123):57-65. Available from: PubMed PMID: 22379175. doi: 10.1183/09059180.00008911. [Google Scholar]

Sanofi Pasteur MSD. Pneumovax II solution for injection in a vial: summary of product characteristics. 2013. Available at: Accessed Aug 18, 2015.

World Health Organization (WHO) , author . 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec 2008;83:373. [Google Scholar]

Advisory Committee on Immunization Practices , author . Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2009;150(1):40. Available from: doi: 10.7326/0003-4819-150-1-200901060-00008. [Google Scholar]

Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009 Jan;180(1):48-58. Available from: PubMed PMID: 19124790. doi: 10.1503/cmaj.080734. [Google Scholar]

Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults.. Cochrane Database Syst Rev 2008 Jan;1(1). PubMed PMID: 18253977. doi: 10.1002/14651858.CD000422.pub2. [Google Scholar]

Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.. N Engl J Med 1991 Nov;325(21):1453-1460. Available from: PubMed PMID: 1944423. doi: 10.1056/NEJM199111213252101. [Google Scholar]

Andrews NJ, Waight PA, George RC, Slack MPE, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine 2012;30(48):6802-6808. Available from: PubMed PMID: 23000122. doi: 10.1016/j.vaccine.2012.09.019. [Google Scholar]

Pfizer. Prevenar: summary of product characteristics. 2013. Available at: Accessed Aug 18, 2015.

GlaxoSmithKline. Synflorix suspension for injection in pre-filled syringe: summary of product characteristics. 2012. Available at: Accessed Aug 18, 2015.

Pfizer. Prevenar 13 suspension for injection: summary of product characteristics. 2015. Available at: Accessed Aug 18, 2015.

Centers for Disease Control and Prevention (CDC) , author . Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep 2013;62:308. [Google Scholar]

Hanna JN, Humphreys JL, Murphy DM, Smith HV. Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009.. Med J Aust 2010 Oct;193(7):392-396. Available from: PubMed PMID: 20919968. [Google Scholar]

Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, Howitz M, et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 2010;28(14):2642-2647. Available from: PubMed PMID: 20096392. doi: 10.1016/j.vaccine.2010.01.017. [Google Scholar]

Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011;11(10):760-768. Available from: PubMed PMID: 21621466. doi: 10.1016/S1473-3099(11)70090-1. [Google Scholar]

Pilishvili T, Lexau C, Farley MM, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201(1):32-41. Available from: PubMed PMID: 19947881. doi: 10.1086/648593. [Google Scholar]

Elston JWT, Santaniello-newton A, Meigh JA, Harmer D, Allgar V, Allison T, et al. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002–2009. Epidemiol. Infect 2012;140(07):1252-1266. Available from: doi: 10.1017/S0950268811001907. [Google Scholar]

Castiglia P. Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe.. Adv Ther 2014 Oct;31(10):1011-1044. Available from: PubMed PMID: 25300593. doi: 10.1007/s12325-014-0157-1. [Google Scholar]

Pebody RG, Leino T, Nohynek H, Hellenbrand W, Salmaso S, Ruutu P. Pneumococcal vaccination policy in Europe.. Euro Surveill 2005;10(9):174-178. Available from: PubMed PMID: 16280609. [Google Scholar]

Bonten MJ, Huijts SM, Bolkenbaas M, , CAPITA Coauthors. . Vaccine against Pneumococcal Pneumonia in Adults.. . Available

from: PubMed PMID: 26132952. doi: 10.1056/NEJMc1505366.. [Google Scholar]

Metersky ML, Dransfield MT, Jackson LA. Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine. Chest 2010;138(3):486-490. Available from: doi: 10.1378/chest.10-0738. [Google Scholar]

Monto AS, Terpenning MS. The value of influenza and pneumococcal vaccines in the elderly.. Drugs Aging 1996;8(6):445-451. Available from: PubMed PMID: 8736628. doi: 10.2165/00002512-199608060-00006. [Google Scholar]

Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010;28(31):4955-4960. Available from: PubMed PMID: 20576535. doi: 10.1016/j.vaccine.2010.05.030. [Google Scholar]

Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.. Clin Diagn Lab Immunol 2003;10(4):514-519. Available from: PubMed PMID: 12853378. [Google Scholar]

Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.. Clin Infect Dis 1999;29(2):281-288. Available from: PubMed PMID: 10476727. doi: 10.1086/520200. [Google Scholar]

Johnson SE, Rubin L, Romero-Steiner S, et al. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis 1999;180(1):133-140. Available from: doi: 10.1086/314845. [Google Scholar]

Schuerman L, Prymula R, Henckaerts I, Poolman J. ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media. Vaccine 2007;25(11):1962-1968. Available from: doi: 10.1016/j.vaccine.2006.12.008. [Google Scholar]

Cherian T, John TJ, Simoes E, Steinhoff MC, John M. Evaluation of simple clinical signs for the diagnosis of acute lower respiratory tract infection.. Lancet 1988 Jul;2(8603):125-128. Available from: PubMed PMID: 2899187. [Google Scholar]

Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines.. 2015 Nov. Available from: PubMed PMID: 26116257. doi: 10.1016/j.vaccine.2015.05.102.. [Google Scholar]

Turner P, Turner C, Kaewcharernnet N, Mon NY, Goldblatt D, Nosten F. A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage. BMC Infect Dis 2011;11(1):108. Available from: PubMed PMID: 21521533. doi: 10.1186/1471-2334-11-108. [Google Scholar]

Ishida T, Hashimoto T, Arita M, Tojo Y, Tachibana H, Jinnai M. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother 2004;10(6):359-363. Available from: PubMed PMID: 15614462. doi: 10.1007/s10156-004-0351-1. [Google Scholar]

Sinclair A, Xie X, Teltscher M, Dendukuri N. Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae.. J Clin Microbiol 2013 May;51(7):2303-2310. Available from: PubMed PMID: 23678060. doi: 10.1128/JCM.00137-13. [Google Scholar]

Murdoch DR, Laing RT, Mills GD, Karalus NC, Town GI, Mirrett S, et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia.. J Clin Microbiol 2001;39(10):3495-3498. Available from: PubMed PMID: 11574562. doi: 10.1128/JCM.39.10.3495-3498.2001. [Google Scholar]

Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 2014;20:45-51. Available from: PubMed PMID: 24313448. doi: 10.1111/1469-0691.12461. [Google Scholar]

Rello J, Lisboa T, Lujan M, et al. DNA-Neumococo Study Group. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009;136(3):832-840. Available from: doi: 10.1378/chest.09-0258. [Google Scholar]

Smith MD, Sheppard CL, Hogan A, et al. South West Pneumococcus Study Group. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J Clin Microbiol 2009;47(4):1046-1049. Available from: doi: 10.1128/JCM.01480-08. [Google Scholar]

Millar BC, Xu J, Moore JE. Molecular diagnostics of medically important bacterial infections.. Curr Issues Mol Biol 2007;9(1):21-39. Available from: PubMed PMID: 17263144. [Google Scholar]

Cremers AJH, Hagen F, Hermans PWM, Meis JF, Ferwerda G. Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections. Eur J Clin Microbiol Infect Dis 2014 Jan;33(7):1119-1124. Available from: PubMed PMID: 24449347. doi: 10.1007/s10096-014-2050-x. [Google Scholar]

Elberse K, van Mens S, Cremers AJ, Meijvis SCA, Vlaminckx B, de Jonge MI, et al. Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples. BMC Infect Dis 2015;15(1):56. Available from: PubMed PMID: 25885896. doi: 10.1186/s12879-015-0788-0. [Google Scholar]

Melegaro A, Edmunds WJ, Pebody R, Miller E, George R. The current burden of pneumococcal disease in England and Wales. J Infect 2006;52(1):37-48. Available from: PubMed PMID: 16368459. doi: 10.1016/j.jinf.2005.02.008. [Google Scholar]